ENZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ENZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Enzo Biochem's Free Cash Flow per Share for the three months ended in Jan. 2024 was $-0.18.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -25.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -50.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Enzo Biochem was 158.40% per year. The lowest was -113.00% per year. And the median was 8.75% per year.
For the Diagnostics & Research subindustry, Enzo Biochem's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
Enzo Biochem (NYSE:ENZ) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Thank you for viewing the detailed overview of Enzo Biochem's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Steven J Pully | director | 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042 |
James G. Wolf | 10 percent owner | 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455 |
Hamid Erfanian | officer: Chief Executive Officer | 527 MADISON AVENUE, NEW YORK NY 10022 |
Patricia Eckert | officer: Interim CFO | C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735 |
Kara Cannon | officer: Chief Operating Officer | 527 MADISON AVE, NEW YORK NY 10022 |
Bradley Louis Radoff | director | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
David Bench | officer: CHIEF FINANCIAL OFFICER | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Harbert Discovery Fund, Lp | 10 percent owner | HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Ian B. Walters | director | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Mary Tagliaferri | director | 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Clemens Peter J Iv | 10 percent owner | 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069 |
Rebecca J. Fischer | director | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Fabian Blank | 10 percent owner, other: See Remarks | ROEMERSTRASSE 6, BAD BERTRICH 2M 56864 |
Harbert Management Corp | 10 percent owner | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Harbert Discovery Co-investment Fund I Gp, Llc | 10 percent owner | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-06-2022
By GuruFocusNews GuruFocusNews • 04-06-2022
By GuruFocusNews GuruFocusNews • 06-06-2022
By PurpleRose PurpleRose • 07-12-2022
By Marketwired • 10-30-2023
By GlobeNewswire GlobeNewswire • 06-02-2022
By GuruFocusNews GuruFocusNews • 06-16-2022
By PRNewswire PRNewswire • 05-03-2023
By sperokesalga sperokesalga • 04-24-2023
By PurpleRose PurpleRose • 08-11-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.